Novel Therapeutic Mechanism of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis via Upregulation of BTG2.
Qinyan YangLi JinQian DingWei HuHaiBo ZouMingming XiaoKeyuan ChenYue YuJin ShangXiaolun HuangQiu-Yan ZhangPublished in: Oxidative medicine and cellular longevity (2022)
AD-MSCs suppresses OA progression through KLF4-induced transcriptional activation of BTG2. Our findings revealed an AD-MSCs-dominated therapeutic method for OA.